ArticleJournal of translational medicine2023

ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma.

Tongyuan Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.